Podoplanin: A novel marker for oral cancer risk in patients with oral premalignancy

Journal of Clinical Oncology

Volumn 26, Issue 3, 2008, Pages 354-360

  Kawaguchi, Hidetoshi ^a   El Naggar, Adel K ^a   Papadimitrakopoulou, Vali ^a   Ren, Hening ^a   Fan, You Hong ^a   Feng, Lei ^a   Lee, J Jack ^a   Kim, Edward ^a   Waun, Ki Hong ^a   Lippman, Scott M ^a   Mao, Li ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PODOPLANIN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 38649137242     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.4072     Document Type: Article

References (24)

1. Waldron CA, Shafer WG: Leukoplakia revisited: A clinicopathologic study 3256 oral leukoplakias. Cancer 36:1386-1392, 1975
2. Silverman S Jr, Gorsky M, Lozada F: Oral leukoplakia and malignant transformation: A follow-up study of 257 patients. Cancer 53:563-568, 1984
3. Papadimitrakopoulou VA, Hong WK, Lee JS, et al: Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: Long-term follow-up. J Natl Cancer Inst 89:257-258, 1997
4. Lippman SM, Hong WK: Molecular markers of the risk of oral cancer. N Engl J Med 344:1323-1326, 2001
5. Mao L, Hong WK, Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 5:311-316, 2004
6. Mao L, Lee J, Fan Y, et al: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignancies. Nat Med 2:682-685, 1996
7. Rosin MP, Cheng X, Poh C, et al: Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 6:357-362, 2000
8. Kahn HJ, Marks A: A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257, 2002
9. Mäkinen T, Veikkola T, Mustjoki S, et al: Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGFC/D receptor VEGFR-3. EMBO J 20:4762-4773, 2001
10. Petrova TV, Makinen T, Makela TP, et al: Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21:4593-4599, 2002
11. Ramirez MI, Millien G, Hinds A, et al: T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol 256:61-72, 2003
12. Schacht V, Ramirez MI, Hong YK, et al: T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 22:3546-3556, 2003
13. Schacht V, Dadras SS, Johnson LA, et al: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166:913-921, 2005
14. Martín-Villar E, Scholl FG, Gamallo C, et al: Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer 113:899-910, 2005
15. Kato Y, Kaneko M, Sata M, et al: Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma. Tumour Biol 26:195-200, 2005
16. Dumoff KL, Chu CS, Harris EE, et al: Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation. Mod Pathol 19:708-716, 2006
17. Wicki A, Lehembre F, Wick N, et al: Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9:261-272, 2006
18. Yuan P, Temam S, El-Naggar A, et al: Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107:563-569, 2006
19. Lee JJ, Hess KR, Dubin JA: Extensions and applications of event charts. Am Stat 54:63-70, 2000
20. Gandarillas A, Scholl FG, Benito N, et al: Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis. Mol Carcinog 20:10-18, 1997
21. Scholl FG, Gamallo C, Vilaró S, et al: Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci 112:4601-4613, 1999
22. Scholl FG, Gamallo C, Quintanilla M: Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression. Lab Invest 80:1749-1759, 2000
23. Partridge M, Pateromichelakis S, Phillips E, et al: A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 60:3893-3898, 2000
24. Jang SJ, Chiba I, Hirai A, et al: Multiple oral squamous epithelial lesions: Are they genetically related? Oncogene 20:2235-2242, 2001